Publicaciones – Página 11

Highly sensitive real-time PCR for the detection of EGFR mutations in lung adenocarcinoma. Is it worth it?

Rodon Natalia¹, Roman Ruth¹, Verdu Montse^1,3, Garcia Beatriz¹, Pujol Merce¹and Puig Xavier^1,2,3.

¹BIOPAT.Biopatologia Molecular, SL, Grup Assistencia, Barcelona, Spain; ²Hospital de Barcelona, SCIAS, Grup Assistencia, Barcelona, Spain; ³Histopat Laboratoris, Barcelona, Spain.

Background: Mutations involving the epidermal growth factor receptor (EGFR) correlate with responsiveness to tyrosine kinase inhibitors (TKIs), which significantly improves patient survival in lung adenocarcinoma (AC). These mutations are described […]

Ana Mª Guardiola 2012-03-14T23:31:31+00:00

ERG Expression in 175 Prostatic Carcinomas and 270 Carcinomas from Different Primary Sites

Verdu Montse^1,3, Roman Ruth1, Calvo Miquel⁴, Rodon Natalia¹, Garcia Beatriz¹, Pujol Merce¹ and Puig Xavier^1,2,3.

¹BIOPAT.Biopatologia Molecular, SL, Grup Assistencia, Barcelona, Spain; ²Hospital de Barcelona, SCIAS, Grup Assistencia, Barcelona, Spain; ³Histopat Laboratoris, Barcelona, Spain; ⁴Universitat de Barcelona(UB), Statistics Dpt., Barcelona, Spain;

Background: ERG gene rearrangement, detected by FISH or RT-PCR, has been identified as a highly specific alteration, present in 40-50% of prostate […]

Ana Mª Guardiola 2012-03-14T23:29:15+00:00

Utilidad del estudio de alteraciones cromosómicas en el diagnóstico y seguimiento de pacientes con carcinoma urotelial

Beatriz García-Peláez¹, Ruth Román¹, Isabel Trias⁴, Naim Hannaoui⁵, Josep M. Banús⁵, Montse Verdú^{1, 3}, Natàlia Rodon¹, Marta Gonzalez¹, Mercè Pujol¹, Myriam Górriz³, Carme Pubill³ y Xavier Puig^1,2,3.

¹ BIOPAT. Biopatología Molecular SL, Grup Assistència. ² Hospital de Barcelona-SCIAS, Grup Assistència. ³ Histopat Laboratoris. ⁴ Hospital Plató. ⁵Institut Català d’ Urologia i Nefrologia SL (ICUN) Barcelona.

Introducción: […]

Ana Mª Guardiola 2011-05-26T15:25:32+00:00
Read More

Clinicopathological and molecular characterization of colorectal micropapillary carcinoma

Montse Verdú^1,2, Ruth Román¹, Miquel Calvo³, Natàlia Rodón¹, Beatriz García¹, Marta González¹, August Vidal^1,2, and Xavier Puig^1,2,4.

¹BIOPAT. Biopatologia Molecular, SL, Grup Assistencia, Barcelona, Spain; ² Histopat Laboratoris, Barcelona, Spain; ³Statistics Department, Universitat de Barcelona, Barcelona, Spain and ⁴Hospital de Barcelona, SCIAS, Grup Assistencia, Barcelona, Spain.

Abstract

Invasive micropapillary carcinoma is associated with frequent lymph node metastasis and […]

Ana Mª Guardiola 2011-05-06T13:52:25+00:00
Read More

Prospective study of HER2 status in 1386 invasive breast carcinomas. The impact of the ASCO/CAP 2007 guidelines.

Montse Verdú^1,2, Marta González¹, Ruth Roman¹, Natalia Rodón¹, Carme Pubill², Begoña Martínez^1,2, Myriam Gorriz², Beatriz Garcia-Pelaez¹, Miquel Calvo⁴ and Xavier Puig^1,2,3.

¹BIOPAT. Biopatologia Molecular, SL, Grup Assistència; ²Histopat Laboratoris; ³Hospital de Barcelona SCIAS, Grup Assistència and ⁴Statistics Department, Universitat de Barcelona. Barcelona, Spain.

Background: The introduction of the ASCO/CAP guidelines in 2007 followed the need to unify methodologies used […]

Ana Mª Guardiola 2011-03-11T18:29:48+00:00
Read More

Previous 9 10 11 12 13 Next

Inicio
Perfil

Equipos profesionales

Protocolo de conservación de muestras

PANELES DE SECUENCIACIÓN MASIVA

Genes BRCA1 y BRCA2

Concordance analysis between liquid biopsy (ctDNA) and tumor DNA molecular profiles from panel-based next-generation sequencing.

N. Rodón et al. Rev Esp Patol   2022;55(3):156-162

Caracterización molecular de biomarcadores para la indicación de inmunoterapia (PD-L1, Inestabilidad de Microsatélites y Tumor Mutational Burden) en una serie de carcinomas neuroendocrinos de pulmón.

N. Rodón et al. Reunión de Primavera de la SEAP 2022

Copy number variation detection for the indication of targeted therapy in a lung cancer patients series. Next-Generation Sequencing panel vs. Fluorescent in-Situ Hibridization.

N. Rodón et al. Congreso Europeo de Patología. 2021.

Concordance analysis between Microsatellite Instability Status and Tumor Mutational Burden in colorectal cancer patients: A nested case-control study.

N.Rodon et al. Congreso de la USCAP. 2020.

Biopsia Líquida (ctDNA) vs Tumor Sólido (FFPE). Comparación de los perfiles moleculares obtenidos mediante NGS en carcinoma pulmonar y colorrectal.

N. Rodon et al. Congreso de la SEAP.so19.

Comparison between matched liquid biopsy (ctDNA) and FFPE tumors molecular profiles of lung and colorectal cancer patients in a molecular diagnostics laboratory.

N. Rodón. Congreso de la USCAP. 2019

Next-Generation Sequencing for ALK and ROS1 rearrangement detection in Non-Small Cell Lung Cancer patients: Implications of FISH positive patterns.

Sergi Clavé, Natàlia Rodon, et al. Clinical Lung Cancer 2019;20(4):421-429

Molecular profiling of lung and colorectal cancer: added value of Next Generation Sequencing.

N. Rodón et al. Conreso Europeo de Patología. 2018.

Secuenciación masiva vs. estudios moleculares gen a gen.

N. Rodón, et al. Congreso de la SEAP. 2017.

A Correlation of RNA-PCA3 urine levels wirh the new grading system in prostate cancer.

N. Rodon et al Rev Esp Patol 2019;52(1):20-26

EGFR mutations in lung cancer. A morphological, inmunohistochemical and molecular study of lung adenocarcinoma.

M. Verdú et al.  Rev Esp Patol 2016;49(4):226-33

Expresión inmunohistoquímica de CK19 en variantes comunes del carcinoma de mama y en subtipos histológicos infrecuentes

García-Peláez et al. Rev Esp Patol 2015;48(2):67-74

Cross-reactivity of EGFR L858 mutation-specific antibody in HER2 positive gastric adenocarcinomas

Verdu et al. Rev Esp Patol 2015;48(2):75-79

Cross-reactivity of EGFR mutation-specific immunochemistry assay in HER2-positive tumors

M. Verdu et al. Appl Immunohistochem Mol Morphol. 2015 Sep: 23(8): 565-70

Prospective validation of the MSI instability prediction models

R. Román et al. Rev Esp Patol. 2015;48(1):2-8

ERG expression and prostatic adenocarcinoma

M. Verdú et al.  Virchow Arch 2013; 462:639-644

Colorrectal micropapillary carcinoma

M Verdú et al. Mod Pathol 2011;24(5):729-38.

The grade group in the new grading system for prostate carcinoma could be predicted by the PCA3 urine test.

N. Rodón et al. Congreso de la USCAP. 2018.

Aportaciones del método OSNA al estudio intraoperatorio del ganglio centinela en pacientes con carcinoma de mama.

R. Román, et al. Congreso de la SEAP. 2015.

RERTEST

MSI-H PREDICTIVE MODEL in colorectal carcinoma

Política de cookies

Política de privacidad y Aviso legal